U.S. markets closed
  • S&P Futures

    3,663.25
    -4.00 (-0.11%)
     
  • Dow Futures

    29,838.00
    -30.00 (-0.10%)
     
  • Nasdaq Futures

    12,466.75
    +12.50 (+0.10%)
     
  • Russell 2000 Futures

    1,834.30
    -3.20 (-0.17%)
     
  • Crude Oil

    45.18
    -0.10 (-0.22%)
     
  • Gold

    1,837.40
    +7.20 (+0.39%)
     
  • Silver

    24.12
    +0.05 (+0.19%)
     
  • EUR/USD

    1.2121
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    0.9480
    +0.0140 (+1.50%)
     
  • Vix

    21.17
    +0.40 (+1.93%)
     
  • GBP/USD

    1.3387
    +0.0011 (+0.08%)
     
  • USD/JPY

    104.4600
    +0.0360 (+0.03%)
     
  • BTC-USD

    19,064.64
    -16.70 (-0.09%)
     
  • CMC Crypto 200

    374.08
    +9.17 (+2.51%)
     
  • FTSE 100

    6,463.39
    +78.66 (+1.23%)
     
  • Nikkei 225

    26,751.85
    -49.13 (-0.18%)
     

Retrophin: 3Q Earnings Snapshot

·1 min read

SAN DIEGO (AP) _ Retrophin Inc. (RTRX) on Thursday reported a loss of $22.5 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 44 cents.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The drug developer posted revenue of $51.1 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $48 million.

Retrophin shares have increased 47% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $20.89, an increase of 68% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RTRX at https://www.zacks.com/ap/RTRX